The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on December 8, non-executive director Guo Huaqing increased his holdings of Keji Pharmaceutical (02171.HK) by 10,000 shares, at a price of HK$17.7 per share, for a total amount of HK$177,000. After the increase in holdings, the latest number of shares held was approximately 218 million shares, with a shareholding ratio of 37.75%.

The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on December 8, non-executive director Guo Huaqing increased his holdings of Keji Pharmaceutical (02171.HK) by 10,000 shares, at a price of HK$17.7 per share, for a total amount of HK$177,000. After the increase in holdings, the latest number of shares held was approximately 218 million shares, with a shareholding ratio of 37.75%.